AcquisitionOther
TCR2 THERAPEUTICS INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
TCR2 THERAPEUTICS INC. -> target
The combined company also has a preclinical pipeline of additional target opportunities with development initially focused on PRAME and CD70.
Open source record (SEC) ↗